Warfarin and other VKA Reversal Table    body {font-family: 'Open Sans', sans-serif;}

### Warfarin and other VKA Reversal Table

_(If patient is unable to tolerate PO vitamin K, IV route may be substituted)_

table.tableizer-table { font-size: 12px; border: 1px solid #CCC; font-family: Arial, Helvetica, sans-serif; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #CCC; } .tableizer-table th { background-color: #104E8B; color: #FFF; font-weight: bold; }

| INR | Clinical Setting | Therapeutic Options |
| --- | --- | --- |
| < 4.5 | No bleeding | Hold warfarin until INR in therapeutic range |
| < 4.5 | Rapid reversal required | Hold warfarin Consider vitamin K 2.5 mg PO. |
| 4.5 - 10 | No bleeding | Hold warfarin until INR in therapeutic range. |
| 4.5 - 10 | Rapid reversal required | Hold warfarin Give vitamin K 2.5 - 5 mg PO. |
| \> 10 | No bleeding | Hold warfarin until INR in therapeutic rangeConsider vitamin K 1.25- 2.5 mg PO |
| \>10 | Rapid reversal required | Hold warfarin Give vitamin K 2.5-5 mg IV |
| Any INR | Non-life threatening major bleed or surgery/procedure requiring emergent reversal. | Hold warfarin  
Give vitamin K 5-10 mg IV infusion over 30 minutes.  
Give Kcentra (4-factor PCC)  
INR: 2.0-3.9: 25 units/kg (max 2500 units)  
INR 4.0 - 6.0: 35 units/kg (max 3500 units)  
INR > 6.0: 50 units/kg (max 5000 units) |
| Any INR | Serious or life threatening bleeding | Hold warfarin  
Give vitamin K 10 mg IV infusion over 30 minutes.  
Give KCentra (4-factor PCC)  
INR unknown: 35 units/kg (max 3500 units)  
INR 1.5 - 6.0: 35 units/kg (max 3500 units)  
INR > 6.0: 50 units/kg (max 5000 units)  
Repeat x 2 q15mins prn if INR remains > 1.5 |

  

American Society of Hematology Self‐Assessment Program, 2013  
Witt. J Thromb Thrombolysis (2016) 41:187–205  
KCentra Package Insert, CSL Behring, 2013  
  
UNC HEALTH CARE GUIDELINE Emergent Anticoagulation Reversal  
https://www.med.unc.edu/emergmed/files/emergent-anticoagulation-reversal-guideline-unc-healthcare.  
Developed by: Leah Hatfield, PharmD, BCPS.  
Reviewed by: Stephan Moll, MD and Abhi Mehrotra, MD  
Last Updated: May 2016  
https://www.med.unc.edu/emergmed/files/emergent-anticoagulation-reversal-guideline-unc-healthcare